Growth Metrics

Lemaitre Vascular (LMAT) Cash & Current Investments (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Cash & Current Investments for 16 consecutive years, with $359.1 million as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 19.82% to $359.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $359.1 million through Dec 2025, up 19.82% year-over-year, with the annual reading at $359.1 million for FY2025, 19.82% up from the prior year.
  • Cash & Current Investments for Q4 2025 was $359.1 million at Lemaitre Vascular, up from $343.1 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $359.1 million in Q4 2025, with the low at $21.8 million in Q2 2021.
  • Average Cash & Current Investments over 5 years is $141.7 million, with a median of $93.6 million recorded in 2023.
  • The sharpest move saw Cash & Current Investments decreased 22.5% in 2021, then skyrocketed 247.87% in 2022.
  • Over 5 years, Cash & Current Investments stood at $70.0 million in 2021, then rose by 18.2% to $82.7 million in 2022, then increased by 27.07% to $105.1 million in 2023, then surged by 185.25% to $299.7 million in 2024, then rose by 19.82% to $359.1 million in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $359.1 million, $343.1 million, and $319.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.